Sign in
Poster: MDS-344: Pevonedistat Plus Azacitidine vs Azacitidine Alone in Higher-Risk Myelodysplastic Syndromes (MDS): Efficacy and Safety Results from Study P-2001 (NCT02610777)
Journal article   Peer reviewed

Poster: MDS-344: Pevonedistat Plus Azacitidine vs Azacitidine Alone in Higher-Risk Myelodysplastic Syndromes (MDS): Efficacy and Safety Results from Study P-2001 (NCT02610777)

Justin Watts, Mikkael Sekeres, Atanas Radinoff, Montserrat Arnan, Marco Cerrano, Patricia Font Lopez, Joshua Zeidner, Maria Diez Campelo, Carlos Graux, Jane Liesveld, …
Clinical lymphoma, myeloma and leukemia, Vol.21, pp.S227-S227
2021-09

Metrics

2 Record Views

Details